In a False Claims Act case in which the relators allege that Mount Sinai Hospital and affiliated entities committed improper billing and wrongful payment retention misconduct, Judge Berman of the United States District Court for the Southern District of New York held that the realtors could use confidential patient records as the basis for their qui tam action. The decision is available here.
In a motion to dismiss, the defendants asserted that the relators “may not rely on improperly obtained confidential patient records as the basis for their complaint.” Judge Berman rejected defendant’s request for preclusion of the patient records, holding that
there is strong public policy in favor of protecting those who report fraud against the government. See U.S. ex rel. Ruhe v. Masimo Corp., 929 F. Supp. 2d 1033, 1039 (C.D. Cal. 2012) (where relators “sought to expose a fraud against the government and limited [obtaining] documents relevant to the alleged fraud … this taking and publication was not wrongful, even in light of nondisclosure agreements, given ‘the strong public policy in favor of protecting whistleblowers who report fraud against the government.”‘) (citing U.S. ex rel. Grandeau v. Cancer Treatment Ctrs. of Am., 350 F. Supp. 2d 765, 773 (N.D. Ill. 2004) (“Relator and the government argue that the confidentiality agreement cannot trump the FCA’s strong policy of protecting whistleblowers who report fraud against the government.”)).
Judge Berman also noted the relators’ contention that HIPPA “carves out an exception that allows ‘whistleblowers’ to reveal such information to governmental authorities and private counsel, provided that they have a good faith belief their employer engaged in unlawful conduct.” The relators are represented by McInnis Law.
As Medicare fraud is estimated to cost taxpayers $60 billion to $90 billion each year, it is critical that the courts do not permit health care providers to use confidentiality agreements to immunize themselves from FCA liability. If confidentiality agreements were deemed to trump the FCA, then the government would lose its most effective tool in combatting health care fraud.
Nevertheless, whistleblowers should seek counsel before using confidential information to bring a whistleblower claim. And whistleblowers should avoid gathering evidence unlawfully and consider taking appropriate measures to protect certain confidential information, such as filing a redacted complaint that does not disclose patient names.
See these related posts and FAQs:
- Court Rules that Whistleblowers Can Use Confidential Company Documents to Expose Fraud
- Retaliatory Lawsuit Against Whistleblower Dismissed on Summary Judgment
- De Facto Gag Clauses: The Legality of Employment Agreements That Undermine Dodd-Frank’s Whistleblower Provisions
- 5 Questions To Ask Before Suing Over Whistleblower Theft
- Forbes Quotes Whistleblower Attorney Jason Zuckerman About Self-Help Discovery in Whistleblower Litigation
- Can Whistleblowers Disclose Secret Recordings to the SEC?
- Is a lawsuit against a whistleblower actionable retaliation?
To learn more about False Claims Act whistleblower protection, see our answers to frequently asked questions about the False Claims Act whistleblower protection law.
The experienced whistleblower lawyers at Zuckerman Law have represented whistleblowers under the qui tam provisions of the False Claims Act and under other whistleblower reward and whistleblower protection laws. To schedule a free preliminary consultation, click here or call us at 202-262-8959.